General Information of Drug Transporter (DT)
DT ID DTD0446 Transporter Info
Gene Name SLC6A14
Transporter Name Amino acid transporter ATB0+
Gene ID
11254
UniProt ID
Q9UN76
Post-Translational Modification of This DT
Overview of SLC6A14 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC6A14 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

155

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A14 Asparagine 155 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC6A14 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

163

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A14 Asparagine 163 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC6A14 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

174

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A14 Asparagine 174 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC6A14 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

189

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A14 Asparagine 189 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC6A14 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

197

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A14 Asparagine 197 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC6A14 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

202

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A14 Asparagine 202 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC6A14 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

230

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A14 Asparagine 230 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC6A14 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

302

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A14 Asparagine 302 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC6A14 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

19

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A14 Serine 19 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC6A14 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

21

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A14 Serine 21 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC6A14 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

22

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A14 Serine 22 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC6A14 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

176

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A14 Serine 176 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC6A14 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

636

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A14 Serine 636 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC6A14 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

638

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A14 Serine 638 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC6A14 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

634

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A14 Threonine 634 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S6A14_HUMAN)
2 Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
3 TiO2 with Tandem Fractionation (TAFT): An Approach for Rapid, Deep, Reproducible, and High-Throughput Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):710-721.
4 Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer. Cell Rep. 2017 Mar 28;18(13):3242-3256.
5 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
6 Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
7 Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.